BUZZ-Hims & Hers rises after BTIG starts coverage with 'buy' rating
** Telehealth firm Hims & Hers Health's HIMS.N shares rise 1.23% to $27.23 premarket
** Brokerage BTIG starts coverage with buy rating, PT $35
** Says co is "disrupting healthcare with tech and convenience"
** Unlike pure tele-health platforms that rely on remote visits, HIMS offers access to medications and treatment plans, so company is better insulated from the risk of more people returning to in-person visits - brokerage
** BTIG estimates that over 50% of HIMS' members have a personalized treatment plan
** Expects revenue growth and demand for GLP-1 and other obesity health products to remain robust
** We believe compounding for GLP-1s is here to stay - BTIG
** HIMS offers compounded versions of Novo Nordisk's NOVOb.CO Wegovy and Ozempic
** Stock more than doubled last year
(Reporting by Sriparna Roy)
Related Articles
[Crypto IPO] Figure Technology Follows Circle and Bullish with Nasdaq Listing Plans
On August 18, U.S.-based blockchain lending firm Figure Technology Solutions Inc. publicly announced it has filed a Form S-1 registration statement with the U.S. Securities and Exchange Commission (SEC), signaling its intent to go public on the Nasdaq Global Market under the ticker symbol FIGR.
Japan July CPI Preview: With Inflation Cooling, Will the Yen Still Rise?
TradingKey - Japan is set to release July inflation data on 22 August 2025. Market consensus predicts that the national Consumer Price Index (CPI) excluding fresh food will see its year-on-year increase slow from 3.3% in June to 3%. While forecasts for headline CPI and CPI excluding food and...
Powell's Jackson Hole Speech: For U.S. Stocks, Hawk or Dove Signal Could Be a Lose-Lose?
TradingKey - As U.S. inflation and labor market data show signs of rebalancing, Treasury traders and Wall Street banks have largely priced in a rate cut at the September FOMC meeting — the first of 2025. Yet both a more dovish-than-expected tone and a potential surprise hawkish signal from Fed Chair
Eurozone Q2 GDP Commentary: Will the Euro's Upward Momentum Persist?
TradingKey - On 14 August 2025, Eurostat published Q2 GDP figures, revealing a drop in the Eurozone's quarter-on-quarter growth from 0.6% in the first quarter to 0.1%. Consequently, annual growth eased from 1.5% to 1.4%. The slowdown primarily stems from the diminishing boost from European...
Bridgewater Associates Q2 2025 13F Analysis: Founder Ray Dalio’s Final Act
TradingKey - Bridgewater Associates, the world’s largest hedge fund and renowned for its macroeconomic analysis, continues to command market respect with its “risk parity” strategy and precise economic cycle timing.
